Zealand Pharma
A Danish biotech company focused on the discovery and development of peptide-based medicines.
Since its founding in 1998, Zealand has has advanced a total of ten drug candidates into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Latest Zealand Pharma News & Features
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze